Edition:
India

Assertio Therapeutics Inc (ASRT.OQ)

ASRT.OQ on NASDAQ Stock Exchange Global Select Market

4.87USD
22 Mar 2019
Change (% chg)

$0.04 (+0.83%)
Prev Close
$4.83
Open
$4.79
Day's High
$5.00
Day's Low
$4.76
Volume
198,056
Avg. Vol
212,955
52-wk High
$9.48
52-wk Low
$3.38

Chart for

About

Assertio Therapeutics, Inc. is a specialty pharmaceutical company. The Company focuses on pain and other central nervous system (CNS) conditions. Its products include NUCYNTA ER (tapentadol extended release tablets), NUCYNTA IR (NUCYNTA) (tapentadol), Gralise (gabapentin), Cambia (diclofenac potassium for oral solution),... (more)

Overall

Beta: 1.19
Market Cap(Mil.): $369.12
Shares Outstanding(Mil.): 62.99
Dividend: --
Yield (%): --

Financials

  ASRT.OQ Industry Sector
P/E (TTM): -- 29.30 32.54
EPS (TTM): -1.79 -- --
ROI: -12.06 14.23 13.82
ROE: -43.53 15.46 15.24

CORRECTED-Intellia CEO not involved in Starboard's Bristol-Myers board challenge

NEW YORK, Feb 28 Intellia Therapeutics Inc Chief Executive John Leonard, who U.S. drug maker Bristol-Myers Squibb Co said last week was nominated by hedge fund Starboard Value LP to sit on its board, is not affiliated with the effort, an Intellia spokeswoman said on Thursday.

02 Mar 2019

Earnings vs. Estimates